Evidence map›Paper›PMID 41031325›Full record

ReviewBeilstein journal of nanotechnology2025

Ambient pressure XPS at MAX IV.

Mattia Scardamaglia, Ulrike Küst, Alexander Klyushin, Rosemary Jones, Jan Knudsen, Robert Temperton, Andrey Shavorskiy, Esko Kokkonen

Abstract readReview
In one paragraph

Review in Beilstein journal of nanotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mattia ScardamagliaMAX IV Laboratory, Lund University, Box 118, SE-221 00, Lund, Sweden.ORCID https://orcid.org/0000-0002-1128-7524
Ulrike KüstDivision of Synchrotron Radiation Research, Lund University, Box 118, SE-221 00, Lund, Sweden.ORCID https://orcid.org/0009-0009-0056-3165
Alexander KlyushinMAX IV Laboratory, Lund University, Box 118, SE-221 00, Lund, Sweden.
Rosemary JonesMAX IV Laboratory, Lund University, Box 118, SE-221 00, Lund, Sweden.ORCID https://orcid.org/0000-0001-6273-4243
Jan KnudsenMAX IV Laboratory, Lund University, Box 118, SE-221 00, Lund, Sweden.
Robert TempertonMAX IV Laboratory, Lund University, Box 118, SE-221 00, Lund, Sweden.
Andrey ShavorskiyMAX IV Laboratory, Lund University, Box 118, SE-221 00, Lund, Sweden.
Esko KokkonenMAX IV Laboratory, Lund University, Box 118, SE-221 00, Lund, Sweden.ORCID https://orcid.org/0000-0002-3674-7486

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ambient pressure X-ray photoelectron spectroscopy (APXPS) has emerged as an important technique for investigating surface and interface chemistry under realistic conditions, overcoming the limitations of conventional XPS restricted to ultrahigh vacuum. This review highlights the capabilities and scientific impact of APXPS at the MAX IV Laboratory, the world's first fourth-generation synchrotron light source. With the APXPS beamlines SPECIES and HIPPIE, MAX IV offers state-of-the-art instrumentation for in situ and operando studies across a broad pressure range, enabling research in catalysis, corrosion, energy storage, and thin film growth. The high brilliance and small beam size of MAX IV's synchrotron light are essential for pushing the time-resolution boundaries of APXPS, especially in the soft X-ray regime. We discuss representative studies at MAX IV, including investigations of single-atom catalysts, confined catalysis, time-resolved catalysis, atomic layer deposition, and electrochemical interfaces, showcasing the role of APXPS in advancing material and surface science.

Indexed as

2D materialsatomic layer depositionbatteriescatalysiscorrosion

Identifiers

PMID41031325
PMCPMC12477903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.